Heart Failure / Aortic Stenosis / Cardiovascular Disease (CVD) · Observational Study

Study of the Progression of Chronic Cardiovascular Conditions

ClinicalTrials.gov · August 12, 2026

Preliminary Why this matters to you Expert discussion

Early or partial results. Treat as a signal, not a conclusion.

AI Summary

This is a planned observational registry study registered on ClinicalTrials.gov that aims to enroll an estimated 5000 participants with various cardiovascular conditions and track their longitudinal clinical status over 90-day cycles. The registry record contains no results, outcome data, or efficacy findings; it describes the study protocol and planned enrollment only.

What was studied

Observational. Cardiovascular Disease (CVD), Heart Failure, Aortic Stenosis, Aortic Stenosis Disease, Hypertension, Hypertension (HTN), Hypertrophic Cardiomyopathy Patients,…; age from 18 Years. Intervention: Cardiovascular Disease (CVD). n = 5,000. 1 site: United States.

Key findings

Safety

This is a registry record, not a published study with results; no efficacy, safety, or clinical outcome data are reported.

Who this may help

The source did not state who this applies to in practice.

Plain-language summary

This is an ongoing observational registry study with no results reported; it describes planned enrollment and outcome measures only, without any efficacy or safety data.

Study design

As stated by the source record.

MethodsCohort model. Prospective time perspective. Primary outcome measures: Longitudinal Assessment of Clinical Status (assessed at Baseline through each 90-day cycle); Longitudinal Assessment of Clinical Status (assessed at Baseline through each 90-day cycle); Longitudinal Assessment of Clinical Status (assessed at Baseline through each 90-day cycle); Longitudinal Assessment of Clinical Status (assessed at Baseline through each 90-day cycle)

DesignObservational

PopulationCardiovascular Disease (CVD), Heart Failure, Aortic Stenosis, Aortic Stenosis Disease, Hypertension, Hypertension (HTN), Hypertrophic Cardiomyopathy Patients,…; age from 18 Years

Sample size5,000

InterventionCardiovascular Disease (CVD)

Setting1 site: United States

Reported figures

Quoted from the source exactly as published.

Planned enrollment5000

Primary outcome measureLongitudinal Assessment of Clinical Status, Baseline through each 90-day cycle

Study typeOBSERVATIONAL

Recruitment statusRECRUITING

Caveats

This is a registry record, not a published study with results; no efficacy, safety, or clinical outcome data are reported.
Primary outcome is described as 'Longitudinal Assessment of Clinical Status' but specific measures, scales, or endpoints are not detailed.
No information provided on follow-up duration, data collection methods, analysis plan, or expected completion date.
Enrollment is estimated; actual sample size and recruitment completion status unknown.

Evidence assessment

Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.

Study design

moderate

Observational, prospective design; no control arm or randomization.

Directness

moderate

Longitudinal assessment of clinical status in cardiovascular disease patients over time.

Consistency

insufficient

No results reported; consistency cannot be assessed.

Risk of bias

insufficient

No methods detail on blinding, data quality, or loss to follow-up reported.

Sample adequacy

moderate

Estimated enrollment 5000 participants; planned size adequate for registry purposes.

What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.

Source abstract

Registry record from ClinicalTrials.gov (NCT07420907). This is a study registration, not published results. Lead sponsor: Prolaio. Recruitment status: RECRUITING. Study type: OBSERVATIONAL. Enrollment: 5000 participants (ESTIMATED). Conditions: Cardiovascular Disease (CVD), Heart Failure, Aortic Stenosis, Aortic Stenosis Disease, Hypertension, Hypertension (HTN), Hypertrophic Cardiomyopathy Patients, Hypertrophic Cardiomyopathy Without Obstruction, Hypertrophic Cardiomyopathy, Obstructive, Dilated Cardiomyopathy (DCM), Dilated Cardiomyopathy, Dilated Cardiomyopathy, Familial. Primary outcome measures: Longitudinal Assessment of Clinical Status , Baseline through each 90-day cycle; Longitudinal Assessment of Clinical Status , Baseline through each 90-day cycle; Longitudinal Assessment of Clinical Status , Baseline through each 90-day cycle; Longitudinal Assessment of Clinical Status , Baseline through each 90-day cycle. Brief summary: This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.

Follow from this

Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.

Heart FailureNCT07420907Aortic StenosisProlaioCardiovascular Disease (CVD)